导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -10.93% | 3802/4763 |
| 近一周 | -3.50% | 4784/5452 |
| 近一月 | 2.47% | 214/5409 |
| 近一季 | -3.03% | 1532/5219 |
| 近半年 | -13.95% | 3938/4908 |
| 近一年 | 1.89% | 2390/4388 |
| 近两年 | 28.64% | 2342/2951 |
| 近三年 | 5.18% | 1834/2250 |
| 成立以来 | 18.01% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-3.27% 3103/4961 |
-4.68% 3524/5312 |
- - |
- - |
| 2025 | 18.78% 2281/4813 |
-5.09% 3255/3635 |
10.95% 226/4076 |
4.75% 3654/4524 |
7.69% 283/4813 |
| 2024 | 8.69% 1529/3463 |
-7.15% 2125/2808 |
4.00% 240/3014 |
12.49% 2332/3129 |
0.06% 1277/3463 |
| 2023 | -18.01% 1776/2656 |
-7.80% 2176/2280 |
4.49% 82/2385 |
-9.40% 1812/2515 |
-6.07% 1620/2655 |
| 2022 | -23.67% 1156/2207 |
-24.66% 1774/1919 |
8.48% 359/2016 |
-3.82% 43/2113 |
-2.90% 1820/2208 |
| 2021 | 19.49% 191/1822 |
-19.05% 1208/1255 |
11.28% 383/1330 |
10.82% 117/1466 |
19.70% 29/1822 |
| 2020 | 71.09% 65/1250 |
-4.80% 380/1022 |
9.87% 776/1060 |
30.26% 10/1152 |
- - |
| 2019 | 25.12% 606/1092 |
34.53% 107/748 |
-9.20% 634/797 |
2.74% 285/844 |
-0.30% 882/912 |
| 2018 | -28.03% 434/834 |
- - |
- - |
- - |
-13.53% 539/691 |
| 2017 | -17.79% 573/714 |
- - |
- - |
- - |
- - |
| 2016 | -23.91% 467/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 前海开源中航军工指数A VS. 长安沪深300非周期A(740101) |